Potential use of EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma with chemoresistanceAyumi Kanemaru, Hirofumi Jono|Cancer Cell International|2022Cited by 10